I posted this in another thread but thought it was worth creating a new thread for. Just found this link to a new interview with Roger Aston discussing the Phase 2 Canine trial. He discusses the trial, clarifies 'stable disease', the Elanco option, human trials and more. Very much worth a watch. Brings me more confidence to hear it from him personally.
https://www.youtube.com/watch?v=73rIH2s5Tbg&feature=youtu.be
If link doesn't work, type "PharmAust (ASX PAA) Q&A" into YouTube by the channel "TechInvest Magazine"
Roger Aston Interview May 2020
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.010(5.56%) |
Mkt cap ! $67.30M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 16.3¢ | $581.7K | 3.408M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 502428 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 40529 | 1 |
View Market Depth
| Last trade - 16.10pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
17.5¢ |
Change
-0.010 ( 3.15 %) |
||||
| Open | High | Low | Volume | ||
| 17.5¢ | 18.0¢ | 16.0¢ | 3492891 | ||
| Last updated 15.59pm 10/05/2024 ? | |||||
| PAA (ASX) Chart |